MedPath

Treatment Satisfaction in Implantable Cardioverter Defibrillator Recipients

Phase 4
Completed
Conditions
Improvement of Treatment Satisfaction
Interventions
Device: Home-Monitoring
Device: Follow-up by Home-Monitoring
Registration Number
NCT01230073
Lead Sponsor
Deutsches Herzzentrum Muenchen
Brief Summary

Remote monitoring of implantable cardioverter defibrillators (ICD) is a promising new development in ICD therapy and has been shown to be technically feasible and safe.While data on safety and feasibility of remote monitoring are in favour of this technology, patients´ treatment satisfaction has not been sufficiently investigated. To date, there is only one small, non-randomised study investigating patients´ treatment satisfaction in highly selected and highly motivated patients at the time of implantation and 12 months thereafter7. Therefore, the aim of the San Remo Trial is to investigate factors that are associated with patients´ willingness to accept the new method of follow-up on a broad basis of ICD recipients and to determine their treatment satisfaction with ICD therapy in a randomised, prospective trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • ICD indication according to current national or international guidelines
  • Patient available for follow-up during study period
Exclusion Criteria
  • Clinically unstable medical conditions that require regular outpatient clinic follow-up

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ICD traditional follow-upFollow-up by Home-MonitoringICD with traditional follow-up in the outpatient clinic
Home-MonitoringHome-MonitoringHome-Monitoring
ICD traditional follow-upHome-MonitoringICD with traditional follow-up in the outpatient clinic
Home-MonitoringFollow-up by Home-MonitoringHome-Monitoring
Primary Outcome Measures
NameTimeMethod
Treatment satisfaction with ICD therapy and follow-up12 months
Secondary Outcome Measures
NameTimeMethod
Number of healthcare consultations12 months

Trial Locations

Locations (1)

Deutsches Hezzentrum

🇩🇪

München, Bavaria, Germany

© Copyright 2025. All Rights Reserved by MedPath